Alvameline
Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
Link from a Wikipage to another Wikipage
differentFrom
primaryTopic
Alvameline
Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
has abstract
Alvameline (Lu 25-109) is a M1 ...... was subsequently discontinued.
@en
CAS number
120241-31-8
ChEMBL
FDA UNII code
4XFD7B36M6
PubChem
Wikipage page ID
25,288,529
page length (characters) of wiki page
Wikipage revision ID
970,045,205
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChEMBL
ChemSpiderID
date
June 2017
@en
IUPAC name
PubChem
reason
something is missing here, the example implied by the form of words "as in" ...
@en
small
left
@en
SMILES
n1nnCC
@en
StdInChIKey
RNMOMKCRCIRYCZ-UHFFFAOYSA-N
@en
verifiedrevid
437,146,314
wikiPageUsesTemplate
hypernym
comment
Alvameline (Lu 25-109) is a M1 ...... was subsequently discontinued.
@en
label
Alvameline
@en